$LIV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SAMARITAN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SAMARITAN PHARMACEUTICALS INC. Get notifications about new insider transactions in SAMARITAN PHARMACEUTICALS INC for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 15 2008 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Grant | A | 0.20 | 435,000 | 86,130 | 435,000 | 0 to 435 K |
Sep 15 2008 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Sell | D | 0.20 | 435,000 | 86,130 | 674,207 | 1.1 M to 674.2 K (-39.22 %) |
Sep 15 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Option Exercise | A | 0.19 | 57,895 | 11,000 | 57,895 | |
Sep 15 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Grant | A | 0.20 | 1,000,000 | 197,000 | 1,000,000 | 0 to 1000 K |
Sep 15 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Sell | D | 0.20 | 1,000,000 | 197,000 | 833,356 | 1.8 M to 833.4 K (-54.54 %) |
Aug 11 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Option Exercise | A | 0.25 | 60,000 | 15,000 | 60,000 | |
Jul 29 2008 | LIV | SAMARITAN PHARMACE ... | Weaver George A Jr | Grant | A | 0.20 | 112,465 | 22,493 | 112,465 | 0 to 112.5 K | |
Jul 29 2008 | LIV | SAMARITAN PHARMACE ... | Lang Thomas Arnold | Chief Drug Developm ... | Grant | A | 0.20 | 162,239 | 32,448 | 162,239 | 0 to 162.2 K |
Jul 29 2008 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Option Exercise | A | 0.25 | 120,000 | 30,000 | 120,000 | |
Jul 29 2008 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Grant | A | 0.20 | 496,512 | 99,302 | 1,109,207 | 612.7 K to 1.1 M (+81.04 %) |
Jul 29 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Grant | A | 0.20 | 827,646 | 165,529 | 1,833,356 | 1 M to 1.8 M (+82.29 %) |
Apr 04 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Option Exercise | A | 0.33 | 1,060,606 | 350,000 | 1,060,606 | |
Jan 08 2008 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Grant | A | 0.35 | 529,361 | 185,276 | 612,695 | 83.3 K to 612.7 K (+635.23 %) |
Jan 08 2008 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Sell | D | 0.35 | 529,361 | 185,276 | 1,683,065 | 2.2 M to 1.7 M (-23.93 %) |
Jan 08 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Grant | A | 0.35 | 672,376 | 235,332 | 839,043 | 166.7 K to 839 K (+403.42 %) |
Jan 08 2008 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Sell | D | 0.35 | 672,376 | 235,332 | 2,302,070 | 3 M to 2.3 M (-22.61 %) |
Dec 17 2007 | LIV | SAMARITAN PHARMACE ... | HOLDEN WELTER | Director | Grant | A | 0.00 | 40,000 | 0 | 126,373 | 86.4 K to 126.4 K (+46.31 %) |
Dec 17 2007 | LIV | SAMARITAN PHARMACE ... | THOMPSON CYNTHIA C | Director | Grant | A | 0.00 | 175,000 | 0 | 191,667 | 16.7 K to 191.7 K (+1,049.98 %) |
Dec 17 2007 | LIV | SAMARITAN PHARMACE ... | WINN H THOMAS | Director | Grant | A | 0.00 | 137,500 | 0 | 150,834 | 13.3 K to 150.8 K (+1,031.20 %) |
Dec 17 2007 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Option Exercise | A | 0.49 | 187,500 | 91,875 | 187,500 | |
Dec 17 2007 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Grant | A | 0.00 | 474,895 | 0 | 2,212,426 | 1.7 M to 2.2 M (+27.33 %) |
Dec 17 2007 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Grant | A | 0.00 | 37,500 | 0 | 40,834 | 3.3 K to 40.8 K (+1,124.78 %) |
Dec 17 2007 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Option Exercise | A | 0.49 | 250,000 | 122,500 | 250,000 | |
Dec 17 2007 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Grant | A | 0.00 | 1,424,694 | 0 | 2,974,446 | 1.5 M to 3 M (+91.93 %) |
Dec 17 2007 | LIV | SAMARITAN PHARMACE ... | Garcia Julio L. | Director | Grant | A | 0.00 | 37,500 | 0 | 37,500 | 0 to 37.5 K |
Dec 17 2007 | LIV | SAMARITAN PHARMACE ... | Weaver George A Jr | Option Exercise | A | 0.49 | 75,000 | 36,750 | 75,000 | ||
Dec 17 2007 | LIV | SAMARITAN PHARMACE ... | Weaver George A Jr | Grant | A | 0.00 | 74,765 | 0 | 224,785 | 150 K to 224.8 K (+49.84 %) | |
Jun 13 2007 | LIV | SAMARITAN PHARMACE ... | PAPADOPOULOS VASSILI DR | Option Exercise | A | 0.30 | 250,000 | 75,000 | 250,000 | ||
Feb 12 2007 | LIV | SAMARITAN PHARMACE ... | Weaver George A Jr | Grant | A | 0.40 | 225,000 | 90,000 | 825,117 | 600.1 K to 825.1 K (+37.49 %) | |
Jan 12 2007 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Sell | D | 0.19 | 1,000,000 | 190,000 | 15,746,151 | 16.7 M to 15.7 M (-5.97 %) |
Jan 12 2007 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Grant | A | 0.19 | 1,000,000 | 190,000 | 16,746,151 | 15.7 M to 16.7 M (+6.35 %) |
Jan 12 2007 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Sell | D | 0.19 | 1,000,000 | 190,000 | 16,746,151 | 17.7 M to 16.7 M (-5.64 %) |
Jan 04 2007 | LIV | SAMARITAN PHARMACE ... | BESSERT DOUGLAS | Director | Grant | A | 0.20 | 4,000,000 | 800,000 | 4,875,855 | 875.9 K to 4.9 M (+456.70 %) |
Jan 04 2007 | LIV | SAMARITAN PHARMACE ... | BESSERT DOUGLAS | Director | Sell | D | 0.20 | 4,000,000 | 800,000 | 4,875,855 | 8.9 M to 4.9 M (-45.07 %) |
Jan 04 2007 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Grant | A | 0.20 | 2,000,000 | 400,000 | 16,746,151 | 14.7 M to 16.7 M (+13.56 %) |
Jan 04 2007 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Sell | D | 0.20 | 2,000,000 | 400,000 | 16,746,151 | 18.7 M to 16.7 M (-10.67 %) |
Jan 04 2007 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Grant | A | 0.20 | 500,000 | 100,000 | 12,432,292 | 11.9 M to 12.4 M (+4.19 %) |
Jan 04 2007 | LIV | SAMARITAN PHARMACE ... | BOYLE EUGENE | Chief Financial Off ... | Sell | D | 0.20 | 500,000 | 100,000 | 12,432,292 | 12.9 M to 12.4 M (-3.87 %) |
Jan 03 2007 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Gift | G | 0.21 | 1,000,000 | 210,000 | 12,298,509 | 13.3 M to 12.3 M (-7.52 %) |
Jan 03 2007 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Grant | A | 0.21 | 1,000,000 | 210,000 | 13,298,509 | 12.3 M to 13.3 M (+8.13 %) |
Jan 03 2007 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Sell | D | 0.21 | 1,000,000 | 210,000 | 13,298,509 | 14.3 M to 13.3 M (-6.99 %) |
Dec 21 2006 | LIV | SAMARITAN PHARMACE ... | Weaver George A Jr | Option Exercise | A | 0.25 | 60,000 | 15,000 | 60,000 | ||
Oct 24 2006 | LIV | SAMARITAN PHARMACE ... | BESSERT DOUGLAS | Director | Grant | A | 0.27 | 855,855 | 231,081 | 4,855,855 | 4 M to 4.9 M (+21.40 %) |
Oct 24 2006 | LIV | SAMARITAN PHARMACE ... | BESSERT DOUGLAS | Director | Sell | D | 0.27 | 855,855 | 231,081 | 4,855,855 | 5.7 M to 4.9 M (-14.98 %) |
Oct 24 2006 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Grant | A | 0.27 | 2,000,000 | 540,000 | 13,298,509 | 11.3 M to 13.3 M (+17.70 %) |
Oct 24 2006 | LIV | SAMARITAN PHARMACE ... | GREESON JANET | Chief Executive Off ... | Sell | D | 0.27 | 2,000,000 | 540,000 | 13,298,509 | 15.3 M to 13.3 M (-13.07 %) |
Aug 08 2006 | LIV | SAMARITAN PHARMACE ... | WINN H THOMAS | Director | Option Exercise | A | 0.44 | 80,000 | 35,200 | 80,000 | |
Aug 08 2006 | LIV | SAMARITAN PHARMACE ... | HOLDEN WELTER | Director | Option Exercise | A | 0.44 | 80,000 | 35,200 | 80,000 | |
Aug 08 2006 | LIV | SAMARITAN PHARMACE ... | THOMPSON CYNTHIA C | Director | Option Exercise | A | 0.44 | 120,000 | 52,800 | 120,000 | |
Aug 08 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Option Exercise | A | 0.44 | 80,000 | 35,200 | 80,000 | |
Aug 08 2006 | LIV | SAMARITAN PHARMACE ... | Lecanu Laurent | Director | Option Exercise | A | 0.44 | 80,000 | 35,200 | 80,000 | |
Aug 08 2006 | LIV | SAMARITAN PHARMACE ... | BESSERT DOUGLAS | Director | Option Exercise | A | 0.44 | 30,000 | 13,200 | 30,000 | |
May 02 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Option Exercise | M | 0.18 | 25,000 | 4,500 | 0 | |
May 02 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Buy | M | 0.18 | 25,000 | 4,500 | 40,380 | 15.4 K to 40.4 K (+162.55 %) |
May 02 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Buy | L | 0.39 | 5,000 | 1,950 | 21,380 | 16.4 K to 21.4 K (+30.53 %) |
May 02 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Buy | L | 0.43 | 550 | 237 | 16,380 | 15.8 K to 16.4 K (+3.47 %) |
May 02 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Buy | L | 0.54 | 450 | 243 | 15,830 | 15.4 K to 15.8 K (+2.93 %) |
May 02 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Buy | L | 0.45 | 650 | 293 | 15,380 | 14.7 K to 15.4 K (+4.41 %) |
May 02 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Buy | L | 0.35 | 2,300 | 805 | 14,730 | 12.4 K to 14.7 K (+18.50 %) |
May 02 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Buy | L | 0.43 | 2,700 | 1,161 | 12,430 | 9.7 K to 12.4 K (+27.75 %) |
May 02 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Buy | L | 0.51 | 2,500 | 1,275 | 9,730 | 7.2 K to 9.7 K (+34.58 %) |
May 02 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Buy | L | 0.53 | 5,000 | 2,650 | 7,230 | 2.2 K to 7.2 K (+224.22 %) |
May 02 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Buy | L | 0.98 | 430 | 421 | 2,230 | 1.8 K to 2.2 K (+23.89 %) |
May 02 2006 | LIV | SAMARITAN PHARMACE ... | SALDI JUGAN DR | Director | Buy | L | 1.27 | 1,800 | 2,286 | 1,800 | 0 to 1.8 K |
Apr 27 2006 | LIV | SAMARITAN PHARMACE ... | HOLDEN WELTER | Director | Option Exercise | M | 0.20 | 200,000 | 40,000 | 200,000 | |
Apr 27 2006 | LIV | SAMARITAN PHARMACE ... | HOLDEN WELTER | Director | Payment of Exercise | F | 0.54 | 74,074 | 40,000 | 1,771,996 | 1.8 M to 1.8 M (-4.01 %) |
Apr 27 2006 | LIV | SAMARITAN PHARMACE ... | HOLDEN WELTER | Director | Buy | M | 0.20 | 200,000 | 40,000 | 1,846,070 | 1.6 M to 1.8 M (+12.15 %) |
Apr 24 2006 | LIV | SAMARITAN PHARMACE ... | WINN H THOMAS | Director | Option Exercise | X | 0.20 | 100,000 | 20,000 | 100,000 | |
Apr 24 2006 | LIV | SAMARITAN PHARMACE ... | WINN H THOMAS | Director | Buy | X | 0.20 | 100,000 | 20,000 | 100,000 | 0 to 100 K |
Apr 24 2006 | LIV | SAMARITAN PHARMACE ... | THOMPSON CYNTHIA C | Director | Option Exercise | X | 0.20 | 100,000 | 20,000 | 0 | |
Apr 24 2006 | LIV | SAMARITAN PHARMACE ... | THOMPSON CYNTHIA C | Director | Buy | X | 0.20 | 100,000 | 20,000 | 110,000 | 10 K to 110 K (+1,000.00 %) |
Page: 1